Literature DB >> 28368254

Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis.

Nima Nabavizadeh1, Timur Mitin2, Laura A Dawson3, Theodore S Hong4, Charles R Thomas2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28368254     DOI： 10.1016/S1470-2045(17)30162-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  PECAM-1 modulates liver damage induced by synergistic effects of TNF-α and irradiation.

Authors:  Gesa Malik; Jörg Wilting; Clemens Friedrich Hess; Giuliano Ramadori; Ihtzaz Ahmed Malik
Journal:  J Cell Mol Med       Date:  2019-02-14       Impact factor: 5.310

2.  Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill Patients.

Authors:  Ihtzaz Ahmed Malik; Giuliano Ramadori
Journal:  Biology (Basel)       Date:  2022-03-18

3.  High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy.

Authors:  Ulrike Bauer; Sabine Gerum; Falk Roeder; Stefan Münch; Stephanie E Combs; Alexander B Philipp; Enrico N De Toni; Martha M Kirstein; Arndt Vogel; Carolin Mogler; Bernhard Haller; Jens Neumann; Rickmer F Braren; Marcus R Makowski; Philipp Paprottka; Markus Guba; Fabian Geisler; Roland M Schmid; Andreas Umgelter; Ursula Ehmer
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.